FGFrederieke A. J. Gigase

Frederieke A. J. Gigase

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Frederieke A. J. Gigase has a total of 132 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigating the association between maternal infection and inflammation and child autistic traits in a large population based cohort study

    by Frederieke A. J. Gigase, Milan Zarchev, Ryan L. Muetzel, Charlotte A. M. Cecil, Luz H. Ospina, Manon H. J. Hillegers, Rebecca Birnbaum, Lot D. de Witte, Veerle Bergink

    Objective Maternal immune activation during pregnancy has been proposed as a mechanism linking prenatal inflammatory exposures to autism pathogenesis. While preclinical and epidemiological studies suggest a role for maternal inflammation and infection, findings in population-based cohorts are inconsistent. This study examined the associations between multiple prenatal inflammatory exposures and autistic traits, accounting for gene-environment interactions in the general pediatric population. Methods We leveraged data from 5,075 mother-child dyads participating in Generation R, a population-based pregnancy cohort in the Netherlands. Prenatal inflammatory exposures included 1) maternal serum cytokines; 2) high-sensitivity CRP; 3) self-reported fever during pregnancy; 4) a maternal polygenic score for CRP; and 5) a methylation profile score of CRP in cord blood. Child autistic traits were measured with the Social Responsiveness Scale at mean ages 6 and 13 years. Linear mixed models were applied to estimate associations adjusted for maternal, child and technical covariates. Interaction terms tested whether child polygenic score for autism moderated associations. Results No significant associations were observed between prenatal inflammatory exposures and autistic traits, both as a continuous measure and above a clinical threshold. No evidence was found for interactions between prenatal inflammatory exposures and the child polygenic score for autism in influencing autistic traits. Conclusion Our findings suggest that typical fluctuations in maternal inflammation are unlikely to represent a major pathway linking prenatal environment to autism risk. We found no evidence that gene-environment interactions conferred additional risk for autistic traits.

  • Open Access

    Inflammatory markers in pregnancy – identifying drivers in four large cohorts

    by Frederieke A. J. Gigase, Anna Suleri, Elena Isaevska, Anna-Sophie Rommel, Myrthe G. B. M. Boekhorst, Olga Dmitrichenko, Hanan El Marroun, Eric A. P. Steegers, Manon H. J. Hillegers, Ryan L. Muetzel, et al.

    Introduction: Adaptations of the immune system throughout gestation have been proposed as important mechanisms regulating successful pregnancy. Dysregulation of the maternal immune system has been associated with adverse maternal and fetal outcomes. The design and interpretation of human biomarker studies require additional insights in the trajectories and drivers of peripheral immune markers. Methods: The current study mapped maternal inflammatory markers (C-reactive protein (CRP), interleukin (IL)-1β, IL-6, IL-17A, IL-23, interferon-γ) during pregnancy and investigated the impact of demographic, environmental and genetic drivers on maternal inflammatory marker levels in four multi-ethnic and socio-economically diverse population-based cohorts with more than 12,000 pregnant participants. Additionally, pregnancy inflammatory markers were compared to pre-pregnancy levels. Results: Cytokines showed a high correlation with each other, but not with CRP. Inflammatory marker levels showed high variability between individuals, yet high concordance within an individual over time during and pre-pregnancy. Pre-pregnancy body mass index (BMI) explained ~ 9.6% of the variance in CRP, but less than 1% of the variance in cytokines. The polygenic score of CRP was the best predictor of variance in CRP (14.1%). Gestational age and previously identified inflammation drivers, including tobacco use and parity, explained less than 1% of variance in both cytokines and CRP.Discussion: Our findings corroborate differential underlying regulatory mechanisms of CRP and cytokines and are suggestive of an individual inflammatory marker baseline which is, in part, genetically driven.


  • Open Access

    Maternal Immune Activation During Pregnancy and Obstetric Outcomes: A Population‐Based Cohort Study

    by Frederieke A. J. Gigase, Myrthe M. G. B. M. Boekhorst, Anna Suleri, Anna‐Sophie Rommel, Michael Breen, Ryan L. Muetzel, Manon H. J. Hillegers, Michal A. Elovitz, Eric A. P. Steegers, Lot D. De Witte, et al.

    Objective: Maternal immune activation has been proposed as a mechanism for adverse pregnancy outcomes, yet the mechanisms and effects of timing remain unclear. Immune disruption in early gestation may be particularly detrimental as this is an important period for placental development, which has been associated with the pathology of adverse obstetric outcomes. To increase our understanding of risk factors for adverse obstetric outcomes, we aim to investigate the association between multiple inflammatory and angiogenic markers during early pregnancy and adverse pregnancy outcomes in a large population‐based cohort.Design: Prospective population‐based pregnancy cohort study (n = 7513).Setting: Rotterdam, the Netherlands.Population: Pregnant women in Rotterdam between April 2002 and January 2006.Methods: Serum inflammatory markers (high‐sensitivity (HS)‐C‐reactive protein (CRP), interleukin (IL)‐1β, IL‐6, IL‐17a, IL‐23, interferon (IFN)‐γ) and angiogenic factors (sFlt‐1 and PlGF) were analysed in repeated measures around 13–20 weeks gestation. A cytokine index was created using principal component analysis.Main Outcome Measures: Hypertensive disorders of pregnancy, spontaneous preterm birth and small for gestational age at birth.Results: HS‐CRP, but not the cytokine index, was associated with increased risk of spontaneous preterm birth after multiple testing correction. We found no association of HS‐CRP or the cytokine index with hypertensive disorders of pregnancy and small for gestational age at birth after multiple testing correction. Inflammatory and angiogenic factors were associated with each other, yet effect sizes were small.Conclusions: We found no strong evidence of a link between early gestation typical inflammatory marker levels and the risk of adverse pregnancy outcomes.


  • Top Cited Papers
    Open Access

    Microglia Exhibit a Unique Intact HIV Reservoir in Human Postmortem Brain Tissue

    by Marieke M. Nühn, Stephanie B. H. Gumbs, Pauline J. Schipper, Irene Drosou, Lavina Gharu, Ninée V. E. J. Buchholtz, Gijsje J. L. J. Snijders, Frederieke A. J. Gigase, Annemarie M. J. Wensing, Jori Symons, et al.

    A proviral reservoir persists within the central nervous system (CNS) of people with HIV, but its characteristics remain poorly understood. Research has primarily focused on cerebrospinal fluid (CSF), as acquiring brain tissue is challenging. We examined size, cellular tropism, and infection-dynamics of the viral reservoir in post-mortem brain tissue from five individuals on and off antiretroviral therapy (ART) across three brain regions. Microglia-enriched fractions (CD11b+) were isolated and levels of intact proviral DNA were quantified (IPDA). Full-length envelope reporter viruses were generated and characterized in CD4+ T cells and monocyte-derived microglia. HIV DNA was observed in microglia-enriched fractions of all individuals, but intact proviruses were identified only in one ART-treated individual, representing 15% of the total proviruses. Phenotypic analyses of clones from this individual showed that 80% replicated efficiently in microglia and CD4+ T cells, while the remaining viruses replicated only in CD4+ T cells. No region-specific effects were observed. These results indicate a distinct HIV brain reservoir in microglia for all individuals, although intact proviruses were detected in only one. Given the unique immune environment of the CNS, the characteristics of microglia, and the challenges associated with targeting these cells, the CNS reservoir should be considered in cure strategies.


  • Open Access

    Inflammatory markers in pregnancy – surprisingly stable. Mapping trajectories and drivers in four large cohorts

    by Frederieke A.J. Gigase, Anna Suleri, Elena Isaevska, Anna-Sophie Rommel, Myrthe G.B.M. Boekhorst, Olga Dmitrichenko, Hanan El Marroun, Eric A.P. Steegers, Manon H.J. Hillegers, Ryan L. Muetzel, et al.

    Adaptations of the immune system throughout gestation have been proposed as important mechanisms regulating successful pregnancy. Dysregulation of the maternal immune system has been associated with adverse maternal and fetal outcomes. To translate findings from mechanistic preclinical studies to human pregnancies, studies of serum immune markers are the mainstay. The design and interpretation of human biomarker studies require additional insights in the trajectories and drivers of peripheral immune markers. The current study mapped maternal inflammatory markers (C-reactive protein (CRP), interleukin (IL)-1β, IL-6, IL-17A, IL-23, interferon- γ ) during pregnancy and investigated the impact of demographic, environmental and genetic drivers on maternal inflammatory marker levels in four multi-ethnic and socio-economically diverse population-based cohorts with more than 12,000 pregnant participants. Additionally, pregnancy inflammatory markers were compared to pre-pregnancy levels. Cytokines showed a high correlation with each other, but not with CRP. Inflammatory marker levels showed high variability between individuals, yet high concordance within an individual over time during and pre-pregnancy. Pre-pregnancy body mass index (BMI) explained more than 9.6% of the variance in CRP, but less than 1% of the variance in cytokines. The polygenic score of CRP was the best predictor of variance in CRP (>14.1%). Gestational age and previously identified inflammation drivers, including tobacco use and parity, explained less than 1% of variance in both cytokines and CRP. Our findings corroborate differential underlying regulatory mechanisms of CRP and cytokines and are suggestive of an individual inflammatory marker baseline which is, in part, genetically driven. While prior research has mainly focused on immune marker changes throughout pregnancy, our study suggests that this field could benefit from a focus on intra-individual factors, including metabolic and genetic components.


  • Open Access

    A microglia-containing cerebral organoid model to study early life immune challenges

    by Alice Buonfiglioli, Raphael Kübler, Roy Missall, Renske De Jong, Stephanie Chan, Verena Haage, Stefan Wendt, Ada J. Lin, Daniele Mattei, Mara Graziani, et al.

    Prenatal infections and activation of the maternal immune system have been proposed to contribute to causing neurodevelopmental disorders (NDDs), chronic conditions often linked to brain abnormalities. Microglia are the resident immune cells of the brain and play a key role in neurodevelopment. Disruption of microglial functions can lead to brain abnormalities and increase the risk of developing NDDs. How the maternal as well as the fetal immune system affect human neurodevelopment and contribute to NDDs remains unclear. An important reason for this knowledge gap is the fact that the impact of exposure to prenatal risk factors has been challenging to study in the human context. Here, we characterized a model of cerebral organoids (CO) with integrated microglia (COiMg). These organoids express typical microglial markers and respond to inflammatory stimuli. The presence of microglia influences cerebral organoid development, including cell density and neural differentiation, and regulates the expression of several ciliated mesenchymal cell markers. Moreover, COiMg and organoids without microglia show similar but also distinct responses to inflammatory stimuli. Additionally, IFN-γ induced significant transcriptional and structural changes in the cerebral organoids, that appear to be regulated by the presence of microglia. Specifically, interferon-gamma (IFN-γ) was found to alter the expression of genes linked to autism. This model provides a valuable tool to study how inflammatory perturbations and microglial presence affect neurodevelopmental processes.


  • Open Access

    SARS-CoV-2 infection, inflammation and birth outcomes in a prospective NYC pregnancy cohort

    by Frederieke A.J. Gigase, Rebecca H. Jessel, Elianna Kaplowitz, Natalie Boychuk, Sophie Ohrn, Erona Ibroci, Juliana Castro, Jezelle Lynch, Rushna Tubassum, Amy Balbierz, et al.


  • Open Access

    The effect of SARS-CoV-2 infection and vaccination on Th17 and regulatory T cells in a pregnancy cohort in NYC

    by Frederieke A. J. Gigase, Mara Graziani, Juliana Castro, Corina Lesseur, Anna-Sophie Rommel, Tammy Flores, M. Mercedes Perez-Rodriguez, Siobhan Dolan, Joanne Stone, Teresa Janevic, et al.

    Disturbances in T-cells, specifically the Th17/Treg balance, have been implicated in adverse pregnancy outcomes. We investigated these two T-cell populations following pre-pregnancy and pregnancy SARS-CoV-2 infection and COVID-19 vaccination in 351 participants from a pregnancy cohort in New York City (Generation C; 2020-2022). SARS-CoV-2 infection status was determined via laboratory or medical diagnosis and COVID-19 vaccination status via survey and electronic medical records data. Peripheral blood mononuclear cells (PBMCs) were collected at routine prenatal visits throughout gestation (median 108 days; IQR 67-191 days) with repeated measures for 104 participants (29.6%). T-cell populations CD4+/CD3+, Th17/CD4+, Treg/CD4+ and the Th17/Treg ratio were quantified using flow cytometry. Results showed that inter-individual differences are a main influencing factor in Th17 and Treg variance, however total variance explained remained small (R2 = 15-39%). Overall, Th17 and Treg populations were not significantly affected by SARS-CoV-2 infection during pregnancy in adjusted linear mixed models (p>0.05), however comparison of repeated measures among SARS-CoV-2 infected participants and non-infected controls suggests a relative increase of the Th17/Treg ratio following infection. In addition, the Th17/Treg ratio was significantly higher after SARS-CoV-2 infection prior to pregnancy (10-138 weeks) compared to controls (β=0.48, p=0.003). COVID-19 vaccination was not associated with Th17 and Treg cells. Our findings suggest an impact of SARS-CoV-2 infection on the Th17/Treg ratio, likely depending on severity of infection, yet the observed trends and their potential consequences for pregnancy outcomes require further investigation. Our study contributes to growing evidence that COVID-19 vaccination during pregnancy does not lead to an exacerbated immune response.


  • Increased postpartum anxiety symptoms after perinatal SARS-CoV-2 infection in a large, prospective pregnancy cohort in New York City

    by Juliana Castro, Frederieke A.J. Gigase, Nina M. Molenaar, Erona Ibroçi, M. Mercedes Perez-Rodriguez, Whitney Lieb, Teresa Janevic, Lot D. de Witte, Veerle Bergink, Anna-Sophie Rommel